MCMINN RACHEL (Chief Executive Officer) received a stock award from NEUROGENE INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/24/2026ACC: 0001606302-26-000002
DirectorOfficer· Chief Executive Officer
Since Feb 2026
+181K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
181K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25.90K
Price / share
—
Trade value
—
% of position
2.0%
2/20/2026
1.32M→1.35M
Total
Net shares
+25.90K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2026 | A · Award | +25.90K | — | — | 2.0% | 1.32M | 1.35M |
| Total | +25.90K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
155.10K shares
Shares
+155.10K
Strike price
17.64
Held after
155.10K
Exercisable
—
2/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock155.10K shares | 2/20/2026 | A · Award | +155.10K | 17.64 | — | 155.10K |